Grad PLUS borrowers stand to gain more from employer Section 127 benefits than any other student-loan population. Grad PLUS loans carry the highest interest rates in the federal portfolio (currently 9.08% for 2025–26 disbursements), and with the OBBBA of 2025 phasing out Grad PLUS for new borrowers after July 2026, every dollar of employer contribution avoids nearly a dime of compounding interest per year.
What Are Grad PLUS Loans?
Grad PLUS is the federal Direct PLUS Loan program for graduate and professional students. Unlike Direct Unsubsidized loans (capped at $20,500/yr for graduate students), Grad PLUS has no annual or aggregate borrowing limit: borrowers can fund the full cost of attendance minus other aid.
- Origination fee: 4.228%
- Credit check: Adverse credit history disqualifies without endorser
- No borrowing cap: Cost of attendance minus other aid
The 2026 OBBBA Phaseout: What Changed
The OBBBA, signed in 2025, terminates Grad PLUS for new borrowers taking out first loans after July 1, 2026. Existing borrowers and continuing students may retain access under transitional rules. Post-2026 graduate students will rely on:
- Direct Unsubsidized Loans (capped at $20,500/yr, aggregate $138,500 including undergrad)
- Private graduate loans at market rates (often 7–14%)
- Institutional aid and scholarships
- Out-of-pocket funding
For high-cost programs — a 4-year medical degree at $250,000+, a 3-year top law school exceeding $300,000 — the Direct Unsubsidized caps leave a shortfall that only private loans can fill, often at higher rates than Grad PLUS.
Why Employer SLRA Matters More After the Phaseout
For existing Grad PLUS borrowers:
- $150,000 Grad PLUS balance at 9.08%: first-year interest = $13,620
- $5,250 employer SLRA applied to principal: saves ~$476 in first-year interest alone
- 10-year payoff with annual $5,250 contributions: cumulative interest savings exceed $18,000, plus ~$1,575/yr in avoided federal tax at a 30% marginal rate
Who This Affects Most
Medical Residents and Fellows
Average med-school debt: ~$200,000, majority Grad PLUS. Residents earning $65,000–$75,000 face crushing payments without IDR. SLRA during residency reduces principal on high-rate debt while IDR keeps monthly payments affordable.
Dental Graduates
Dental school debt averages $300,000+. Practice owners and DSO groups increasingly offer SLRA as a recruitment differentiator.
Law Graduates
AmLaw 200 associates average ~$130,000 in Grad PLUS and Direct Unsubsidized debt. Firms offering SLRA convert taxable bonus dollars into tax-free Section 127 payments.
PhD and Professional Doctorate Borrowers
PsyD, PharmD, DPT, and academic PhDs often rely on Grad PLUS to bridge cost of attendance.
How Section 127 Treats Grad PLUS
Grad PLUS loans are federal Direct Loans and unambiguously qualified education loans under IRC §221(d)(1). Employer contributions are excludable up to $5,250 per year per employee. Integration via MyStudentData from StudentAid.gov auto-imports balances, servicers, and rates.
Worked Examples
Example 1: PGY-3 Medical Resident
Dr. Priya Rao, $72,000 salary. Loans: Grad PLUS $140,000 @ 9.08%; Direct Unsubsidized grad $80,000 @ 6.54%; undergrad $22,000 @ 5.50%. PAYE ~$340/month, PSLF track at a 501(c)(3) hospital. Hospital offers $5,250/yr SLRA → directed to Grad PLUS.
- Interest avoided on Grad PLUS year 1: ~$476
- W-2 tax savings (24% fed + 5% state): ~$1,523
- Total first-year value: ~$7,249 on a $5,250 benefit
Example 2: Fourth-Year Law Associate
Marcus, $265,000 at a mid-size firm. Grad PLUS $165,000 @ 9.08% + private refi $30,000 @ 5.9%. Standard 10-year repayment, no PSLF. Firm offers full $5,250/yr SLRA.
- 10-year principal reduction: $52,500
- Interest avoided (NPV): ~$21,400
- Cumulative tax savings (35%): ~$18,375
- Total 10-year benefit: ~$92,275 on $52,500 contributions
Recruiting Implications for Employers
- $5,250 SLRA ≈ $7,500 pre-tax-equivalent salary at a 30% marginal rate
- Retention: enrolled employees show ~30% lower voluntary turnover years 1–3
- Differentiation: fewer than 10% of employers currently offer SLRA